Figure 3. TTP to symptomatic myeloma stratified based on risk factors (immunoparesis, eHb GBTM, eMP GBTM, and edFLC GBTM). The median times to progression for 0, 1, 2, or ≥3 risk factors were not reached: 77, 26, and 13 months, respectively (P <.0001).
Figure 3.

TTP to symptomatic myeloma stratified based on risk factors (immunoparesis, eHb GBTM, eMP GBTM, and edFLC GBTM). The median times to progression for 0, 1, 2, or ≥3 risk factors were not reached: 77, 26, and 13 months, respectively (P <.0001).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal